NEW YORK (GenomeWeb News) – Oxford Finance today said that it and Silicon Valley Bank have provided a $15 million senior credit facility for molecular diagnostics firm XDx.

The Brisbane, Calif.-based developer of tests for monitoring transplant rejection and autoimmune diseases will use the funds for working capital and for the development of new diagnostic applications using XDx's molecular expression technology.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.